Inflammatory bowel diseases [IBD] are a heterogeneous spectrum with two extreme
phenotypes, Crohn's disease [CD] and ulcerative colitis [UC], which both represent …

Objective We aimed to provide an evidence-supported update of the ECCO-ESPGHAN
guideline on the medical management of paediatric Crohn's disease [CD]. Methods We …

Background & Aims Inflammatory bowel disease (IBD) care and outcomes exhibit
substantial variability, suggesting quality gaps. We aimed to identify interventions to narrow …

Background/purpose Clinical outcomes in pediatric ulcerative colitis (UC) in the era of
biologic agents are poorly defined. We aimed to describe risk factors for colectomy in …

Objectives: Corticosteroids have long been used to treat inflammatory bowel disease.
However, cumulative corticosteroid exposure is associated with adverse effects, particularly …

Background The incidence of pediatric inflammatory bowel diseases (PIBDs: Crohn's
disease [CD], ulcerative colitis [UC]) is on the rise around the world. Yet, the critical risk …

Transition care in inflammatory bowel disease is increasingly recognized as challenging
given the inherent differences between paediatric and adult health care models, disease …

Background/purpose Diagnostic delay or time to diagnosis, and its relationship with
colectomy risk has been studied in adult Inflammatory Bowel Disease (IBD), but rarely in …

Background: In the past decade, significant progress has been achieved in the care of
children with inflammatory bowel disease (IBD). Our study concentrated on assessing the …

Background Management of inflammatory bowel diseases (IBD) is complex and variation in
care has been well-documented. However, the drivers of practice variation remain …